Introduction
Thyroid hormones play a critical role in metabolic homeostasis and significantly influence the human coagulation system. Hyperthyroidism is known to create a procoagulant state, increasing the risk of thrombotic events. While the link between thyroid dysfunction and the occurrence of blood clots is established, the relationship between thyroid status and the physical severity—or extent—of a pulmonary embolism (PE) remains under-explored. This study investigates whether specific thyroid hormone levels correlate with the degree of pulmonary arterial obstruction in patients diagnosed with PE.
Methods
This retrospective cohort study analyzed 118 patients diagnosed with PE at the Affiliated Hospital of Youjiang Medical University for Nationalities between January 2020 and October 2024. The primary measure of PE severity was the computerized tomography (CT) obstruction index, derived from CT pulmonary angiography (CTPA) scans. This index quantifies the percentage of the pulmonary arterial tree blocked by thrombi.
Researchers collected demographic information, clinical history, and laboratory data, including D-dimer levels and a thyroid function panel: free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH). Patients were categorized into two groups based on the median obstruction extent (≤17.5% vs. >17.5%). Statistical analysis employed univariable and multivariable linear regression models to identify independent predictors of thromboembolic extent, adjusting for potential confounders such as age, BMI, and history of deep vein thrombosis.
Results
The study identified a significant association between serum FT3 levels and the extent of pulmonary obstruction. Patients in the high-extent group (>17.5% obstruction) exhibited significantly higher median FT3 levels (4.33 pmol/L) compared to the low-extent group (4.17 pmol/L; p=0.017). Conversely, no significant differences were found for FT4 (p=0.908) or TSH (p=0.273).
Multivariable linear regression confirmed that FT3 is an independent predictor of PE extent (β=0.235, p=0.013). As expected, D-dimer levels also served as a strong independent predictor (β=0.332, p<0.001). The persistence of FT3's predictive value after adjusting for D-dimer suggests it provides unique prognostic information regarding clot severity.
Discussion and Conclusion
The findings suggest that higher serum FT3 levels are independently associated with a greater physical extent of pulmonary thromboembolism. Biologically, T3 is known to stimulate the transcription of coagulation factors like fibrinogen, which may explain this correlation.
While the study is limited by its retrospective design, single-center scope, and relatively small sample size, it highlights the potential clinical utility of thyroid screening in PE management. Identifying patients with elevated FT3 could help clinicians anticipate more extensive blockages. Future prospective, multi-center studies are necessary to validate these findings and further explore the prognostic value of FT3 in predicting clinical outcomes for patients with pulmonary embolism.
Summary updated